Most people think of Staphylococcus as a skin and nose problem, the bacteria behind boils, surgical wound infections, and the antibiotic-resistant strain known as MRSA (methicillin-resistant Staphylococcus aureus). Fewer people realize that these same bacteria can settle into the gut and persist there for months, acting as a hidden source of repeat infections elsewhere in the body.
This stool test counts how many Staphylococcus bacteria are growing in a gram of your stool, giving a snapshot of whether your gut is carrying a quiet population of these organisms. Levels in healthy people are typically very low, so a clearly elevated reading is a signal worth paying attention to, especially if you've had recurring skin infections or recent antibiotic exposure.
The assay is a quantitative stool culture: a small amount of stool is grown on selective media, and any Staphylococcus colonies are counted. The number is reported as colony-forming units per gram of stool (CFU/g stool), where a colony-forming unit represents one viable bacterium that grew into a visible colony in the lab.
Not every Staphylococcus species is dangerous. The genus contains over 40 species, ranging from skin commensals like S. epidermidis (generally harmless on healthy skin but a known troublemaker in hospitalized people with implanted devices) to S. aureus, the most aggressive member of the family. A high number on this test does not automatically mean S. aureus is present, but it does flag that the gut environment is hospitable to staphylococci, which warrants follow-up species-level testing.
The traditional medical focus has been on Staphylococcus carriage in the nose, since roughly a third of healthy adults carry S. aureus in their nostrils. But the gut is increasingly recognized as a parallel reservoir. In a randomized trial of 113 adult veterans, researchers tracked Staphylococcus aureus carriage at multiple body sites and found that the gastrointestinal tract was a meaningful colonization niche, distinct from the nose, throat, and skin.
Why does this matter for you? Bacteria living in the gut can shed onto skin, contaminate surgical sites, and seed bloodstream infections in vulnerable people. People who have repeat boils, recurring cellulitis, or an unexplained pattern of skin infections sometimes carry the same Staph strain in their gut for months, even after the visible infection clears. Knowing whether your gut is part of that picture is information your standard blood panel cannot give you.
A separate concern is that gut Staphylococcus populations are common reservoirs of antibiotic resistance. Coagulase-negative staphylococci (a subgroup that includes S. epidermidis) frequently carry genetic elements that confer methicillin resistance, and these elements can transfer between staphylococcal species. Whole-genome sequencing of clinical isolates increasingly shows resistance to multiple antibiotic classes.
If your gut culture grows out a high count of Staphylococcus, the practical question is which species and what its resistance profile looks like. Identification down to the species level (often using a lab method called MALDI-TOF, which fingerprints bacterial proteins) and antibiotic susceptibility testing change the meaning of the number. A high count of skin-derived S. epidermidis with no resistance genes is very different from a high count of methicillin-resistant S. aureus.
If you've had two or more episodes of boils, abscesses, or cellulitis in a year, gut colonization with Staphylococcus is one of the patterns to investigate. A randomized trial in children with prior skin and soft tissue infections found that prior infection was the strongest predictor of future infection, and that personal and household decolonization strategies reduced recurrence. While that trial focused on nasal and skin decolonization, the underlying logic, removing reservoirs of the bacteria, is the same reason this stool test exists.
Standardized clinical cutpoints for stool Staphylococcus do not yet exist. The available evidence treats the test as a research and screening tool rather than a diagnostic with universal thresholds. Most stool microbiome panels use lab-specific reporting tiers (often shown as the dominant bacteria visible in culture) rather than fixed numeric thresholds.
Because of this, what matters most is the trend in your own samples, processed by the same lab, over time. A stable low-level reading that stays stable is reassuring. A reading that climbs from undetectable to a clear positive, or from low-level to high-level, is the change worth investigating, regardless of where it falls on a generic range.
Gut bacterial counts are inherently variable. Diet, recent antibiotic use, illness, stress, travel, and even bowel transit time can all shift the numbers. A single reading captures one moment in your gut's biology, not a long-term truth. This is why serial testing matters more than any one result.
A reasonable cadence: get a baseline now, retest in 3 to 6 months if you are actively making changes (a probiotic protocol, a course of antibiotics for a different condition, a major diet shift), and at least annually thereafter if you have any history of recurring staphylococcal skin or wound infections. Two or three readings over a year give you a real signal, not a snapshot.
A clearly elevated stool Staphylococcus reading is not a diagnosis. It is a signal to investigate further. The next step is species-level identification and antibiotic susceptibility testing, which most stool microbiome panels can run as a reflex if requested. If S. aureus or methicillin-resistant strains are confirmed and you have a history of recurring infections, that pattern is worth bringing to a doctor familiar with decolonization protocols.
Companion tests that add useful context include a calprotectin level (a stool marker of gut inflammation), pancreatic elastase (a marker of digestive enzyme output that can hint at why your gut environment has shifted), and broader gut microbiome panels that show which beneficial bacteria are present alongside the Staphylococcus. A single elevated reading combined with low beneficial bacteria and elevated calprotectin is a different clinical picture than an isolated elevation in someone whose gut otherwise looks healthy.
Evidence-backed interventions that affect your Staphylococcus Species level
Staphylococcus Species is best interpreted alongside these tests.